4.1 Esophageal cancer In spite of advancements in multidisciplinary antitumor treatment for esophageal cancer (EC), the 5-year survival rate of patients still shows a negative trend, owing to uncharted molecular mechanisms and uncontrolled recurrence ( 154 , 155 ).
← all excerpts
Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers.
1
—
—